A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC
Recruiting · NCT04316364 · Registry updated 2021-11-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 3 | 2021-11-04 | NCT04316364 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 132 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 8 |
| Guangdong Provincial People's Hospital | Guangzhou | China | 25 |
| Henan Cancer Hospital | Zhengzhou | China | 76 |
| Jiangsu Cancer Hospital | Nanjing | China | 19 |
| West China Hospital,Sichuan University | Chengdu | China | 4 |
| Zhejiang Cancer Hospital | Hangzhou | China | 164 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 86 |